186 related articles for article (PubMed ID: 26677760)
1. Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells.
Yin T; Wang G; He S; Liu Q; Sun J; Wang Y
Cell Immunol; 2016 Feb; 300():41-5. PubMed ID: 26677760
[TBL] [Abstract][Full Text] [Related]
2. NK Cells Lose Their Cytotoxicity Function against Cancer Stem Cell-Rich Radiotherapy-Resistant Breast Cancer Cell Populations.
Jin H; Kim HJ
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502547
[TBL] [Abstract][Full Text] [Related]
3. Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity.
Schmohl JU; Felices M; Oh F; Lenvik AJ; Lebeau AM; Panyam J; Miller JS; Vallera DA
Cancer Res Treat; 2017 Oct; 49(4):1140-1152. PubMed ID: 28231426
[TBL] [Abstract][Full Text] [Related]
4. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A
Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
[TBL] [Abstract][Full Text] [Related]
6. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype.
Ames E; Canter RJ; Grossenbacher SK; Mac S; Chen M; Smith RC; Hagino T; Perez-Cunningham J; Sckisel GD; Urayama S; Monjazeb AM; Fragoso RC; Sayers TJ; Murphy WJ
J Immunol; 2015 Oct; 195(8):4010-9. PubMed ID: 26363055
[TBL] [Abstract][Full Text] [Related]
7. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
[TBL] [Abstract][Full Text] [Related]
8. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
Mei JZ; Guo KY; Wei HM; Song CY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
[TBL] [Abstract][Full Text] [Related]
9. Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype.
Brennan K; McSharry BP; Keating S; Petrasca A; O'Reilly VP; Keane J; Doherty DG; Gardiner CM
Hum Immunol; 2016 Oct; 77(10):876-885. PubMed ID: 27349945
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.
Pietra G; Manzini C; Vitale M; Balsamo M; Ognio E; Boitano M; Queirolo P; Moretta L; Mingari MC
Int Immunol; 2009 Jul; 21(7):793-801. PubMed ID: 19491215
[TBL] [Abstract][Full Text] [Related]
11. Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.
Luna JI; Grossenbacher SK; Murphy WJ; Canter RJ
Expert Opin Biol Ther; 2017 Mar; 17(3):313-324. PubMed ID: 27960589
[TBL] [Abstract][Full Text] [Related]
12. Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy.
Park MJ; Bae JH; Chung JS; Kim SH; Kang CD
Immunol Invest; 2011; 40(4):367-82. PubMed ID: 21314289
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer stem-like cells can promote metastasis by activating platelets and down-regulating antitumor activity of natural killer cells.
Wang S; Zhang Y; Cong W; Liu J; Zhang Y; Fan H; Xu Y; Lin H
J Tradit Chin Med; 2016 Aug; 36(4):530-7. PubMed ID: 28459521
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
Zhang C; Zhang J; Niu J; Zhang J; Tian Z
Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
[TBL] [Abstract][Full Text] [Related]
15. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC
Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells.
Ostberg JR; Dayanc BE; Yuan M; Oflazoglu E; Repasky EA
J Leukoc Biol; 2007 Nov; 82(5):1322-31. PubMed ID: 17711975
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of CD24(+) ovarian cancer cells to anti-cancer drugs and natural killer cells.
Koh J; Lee SB; Park H; Lee HJ; Cho NH; Kim J
Biochem Biophys Res Commun; 2012 Oct; 427(2):373-8. PubMed ID: 22995296
[TBL] [Abstract][Full Text] [Related]
18. Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.
Balsamo M; Vermi W; Parodi M; Pietra G; Manzini C; Queirolo P; Lonardi S; Augugliaro R; Moretta A; Facchetti F; Moretta L; Mingari MC; Vitale M
Eur J Immunol; 2012 Jul; 42(7):1833-42. PubMed ID: 22585684
[TBL] [Abstract][Full Text] [Related]
19. Fc-optimized NKG2D-Fc constructs induce NK cell antibody-dependent cellular cytotoxicity against breast cancer cells independently of HER2/neu expression status.
Raab S; Steinbacher J; Schmiedel BJ; Kousis PC; Steinle A; Jung G; Grosse-Hovest L; Salih HR
J Immunol; 2014 Oct; 193(8):4261-72. PubMed ID: 25217158
[TBL] [Abstract][Full Text] [Related]
20. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
Kloess S; Huenecke S; Piechulek D; Esser R; Koch J; Brehm C; Soerensen J; Gardlowski T; Brinkmann A; Bader P; Passweg J; Klingebiel T; Schwabe D; Koehl U
Eur J Immunol; 2010 Nov; 40(11):3255-67. PubMed ID: 21061445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]